DelSiTech Announces Positive Topline Clinical Data From Phase 1 Trial With Its Sustained Release Eye Drop Platform Marcus Reay2023-06-29T11:59:09+03:00June 29th, 2023| Read More
DelSiTech Opens a Cleanroom Facility for Aseptic Manufacturing Marcus Reay2023-05-31T11:05:03+03:00May 31st, 2023| Read More
ChinaBIO Partnering Forum Shanghai, September 20-21 Marcus Reay2023-05-15T10:49:26+03:00May 15th, 2023| Read More
BIO International Convention 2023 Boston, June 5-8 Marcus Reay2023-05-15T10:37:38+03:00May 15th, 2023| Read More
Drug Delivery & Formulation Summit 2023 Berlin, 31st May – 2nd June Marcus Reay2023-05-15T10:24:43+03:00May 15th, 2023| Read More
GeneCellNano 2023 Helsinki, April 13-14 Marcus Reay2023-04-11T14:52:24+03:00April 11th, 2023| Read More
DelSiTech Awarded a Grant to Develop Controlled and Sustained Release Injectables for Prophylactic HIV Vaccine Aleksi Leino2023-03-15T11:34:26+03:00March 15th, 2023| Read More
DelSiTech Ltd Announces Appointment of Dr. Sari Häkkinen as Chief Development Officer Aleksi Leino2023-03-22T16:06:07+03:00March 1st, 2023| Read More
